(uNK) cells make up the majority of leucocytes in the uterine implantation site. 12 Although uNK cells contain perforin and granzyme-filled cytoplasmic granules, they exhibit less cytotoxic activity against major histocompatibility complex class-I-negative target cells, compared with circulating natural killer (NK) cells. 13 Furthermore, uNK cells do not exhibit NK activity against trophoblast cells.
14 In the decidua of preeclamptic patients, changes in uNK cells and T-lymphocyte subsets could affect local immunoregulatory mechanisms. 15 Chakraborty et al 16 showed that in rats, uNK cells are involved in hemochorial placentation by regulating trophoblast cell lineage decisions. Moreover, they presented results showing that endovascular trophoblast cell invasion is increased in wild-type rats during midpregnancy after depletion of uNK cells. However, they did not examine effects on late and pathological pregnancies. Because shallow endovascular trophoblast cell invasion is considered to be causal for the pathological event initiating preeclampsia symptoms and signs, 17 we hypothesized that depletion or reduction of NK cells associated with increased trophoblast cell invasion ameliorates the preeclamptic phenotype in our rat model. We worked with our double-transgenic rat preeclamptic model where the preeclamptic phenotype has been established in rats 18 and mice. 19 The dams expressing human angiotensinogen develop hypertension and proteinuria during pregnancy after mating with males expressing the human renin. 18 The offspring are growth restricted, 20 comparable to what is observed in spontaneously occurring, early-onset preeclampsia in pregnant women. The model exhibits pathological endovascular trophoblast cell invasion with altered uteroplacental vascular remodeling.
21,22

Methods
Local government authorities approved the studies along guidelines provided by the American Physiological Society. Detailed description of methods is available in the online-only Data Supplement.
Analysis of Maternal Uterine Vasculopathy
One uteroplacental unit per mother rat was investigated for analysis of maternal vasculopathy (n=7 anti-asialo GM1-treated, preeclamptic rats versus n=5 normal rabbit serum-treated, control, preeclamptic rats, and n=6 anti-asialo GM1-treated, wild-type, Sprague-Dawley [SD] rats versus n=5 normal rabbit serum-treated, SD control rats). In preeclamptic rats, at least 4 series of sections from the center of the uteroplacental unit were examined per rat. Each series consisted of 10 consecutive sections, 3 µm thick. The distance between the series was 100 µm. In SD rats, at least 15 series of sections from the uteroplacental unit were examined (also covering the central parts). Each series consisted of at least 5 consecutive sections, 3 µm thick. The distance within the series was 100 µm. Terminal deoxynucleotidyl transferase dUTP nick end labeling assay was performed with the TMR In Situ Cell Death Detection Kit (Roche) as recommended by the manufacturer. To visualize cell nuclei, slides were counterstained with the DNA dye Hoechst 33342 (Sigma) and mounted using Vectashield antifade mounting medium (Vector Laboratories). Sections were investigated and imaged by Zeiss Axio Imager M2 fluorescence upright microscope (Zeiss) using either ×10 or ×40 Plan-Apochromat objectives (Zeiss). Pictures were taken with the AxioCam HRc camera (Zeiss).
Statistics
All statistics were done with GraphPad Prism 6. The blood pressure data were analyzed by repeated-measures 2-way ANOVA and Bonferroni multiple comparisons test. With all other data, Grubb test was performed, outliners were excluded (exception: resorption data), and normal distribution calculated by Kolmogorov-Smirnov test or D'Agostino-Pearson omnibus normality test. For group differences, either the unpaired t test (for normally distributed data) or the Mann-Whitney test (for not normally distributed data) was applied. In case of different variances within normally distributed data, an unpaired t test with Welch correction was performed. The quantitative, real-time, reverse transcription polymerase chain reaction results on mesometrial triangle with regard to uNK cells were evaluated with the nonparametric 1-way ANOVA, Kruskal-Wallis test, and Dunn multiple comparisons test. Values are shown as mean±SEM (normally distributed data) or median with interquartile range (not normally distributed data). P values <0.05 were considered significant (*), P<0.01 (**), P<0.001 (***), and P<0.0001 (****).
Results
Reduction of Uterine Natural Killer Cells in Preeclamptic Rats on Pregnancy Day 15 After AntiAsialo GM1 Application
We first investigated whether NK cell reduction on pregnancy day 15 was successful after anti-asialo GM1 therapy in preeclamptic rats. In control, rabbit serum-treated, preeclamptic dams on day 15 of pregnancy, 2.5±0.1% of the splenic lymphocytes were NK cells (CD161 positive and CD3 negative), whereas only 0.5±0.0% of the splenic lymphocytes were NK cells after anti-asialo GM1 treatment, which means that the NK cell population was reduced by 80% ( Figure 1A ). In the mesometrial triangle of the uteroplacental unit of preeclamptic rats, NK cells were also decreased after anti-asialo GM1 therapy ( Figure 1B through 1D ). Immunohistochemical analysis on day 15 of pregnancy demonstrated that uNK cells were present around vessels in control, rabbit serum-treated, preeclamptic rats ( Figure 1B , left) but were significantly reduced after anti-asialo GM1 administration ( Figure 1B , right). Quantification revealed that anti-asialo GM1 treatment reduced the number of uNK cells in the mesometrial triangle of preeclamptic rats by 60% ( Figure 1C ). This finding was confirmed by quantitative, real-time, reverse transcription polymerase chain reaction ( Figure 1D ) in the uteroplacental unit of preeclamptic rats on pregnancy day 15, showing that the mRNA expression of the NK cell marker NKp46 (natural cytotoxicity receptor 1), expressed by all rat conventional NK cells, was decreased by 89%. As expected, uNK cells were hardly present in the uteroplacental unit of preeclamptic rats at the end of pregnancy (day 21), irrespective of anti-asialo GM1 treatment.
Maternal Vasculopathy in the Uterus of Preeclamptic Rats on Pregnancy Day 21 After AntiAsialo GM1 Application
After anti-asialo GM1 application, we found degenerative spiral artery cross sections surrounded by cell detritus and fibrosis in the mesometrial triangle of preeclamptic rats, the maternal part of the uteroplacental unit (Figure 2A through 2E ; Figure S1A through S1E in the online-only Data Supplement). We observed in every anti-asialo GM1-treated, preeclamptic mother rat (7/7, 100%) at least one of such pathological cross section at the end of pregnancy ( Figure 3A) . In control, rabbit serum-treated, preeclamptic mother rats, we found such a lesion in one rat only (1/5, 20%). The vasculopathies were
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characterized by the absence of cell nuclear staining in perivascular cells and in the vascular smooth muscle cells of the vessel wall ( Figure 3B ). Vascular smooth muscle cells were not detectable in these cross sections ( Figure 2C ), and endovascular trophoblast cells were almost totally absent ( Figure 2D ). Moreover, there was increased presence of apoptotic cells within the vasculopathy ( Figure 3B ).
Trophoblast Cell Invasion in Preeclamptic Rats on Pregnancy Day 21 After Anti-asialo GM1 Application
After anti-asialo GM1 application, interstitial trophoblast cell invasion ( Figure S2A ) into the mesometrial triangle of preeclamptic rats was diminished at the end of pregnancy (gestational day 21). In parallel, the number of trophoblast cells in the successfully invaded mesometrial triangle was significantly decreased after anti-asialo GM1 ( Figure S2B ). Endovascular trophoblast cell invasion into the mesometrial triangle of preeclamptic rats (Figure S3A through S3C) was unchanged after anti-asialo GM1 treatment. This finding corresponded to the unchanged amount of vascular smooth muscle α-actin in trophoblast cell-invaded arteries ( Figure  S3D and S3E), indicating an unchanged spiral artery remodeling. The number of spiral artery cross sections in the mesometrial triangle of preeclamptic rats was not different after anti-asialo GM1 treatment (data not shown).
Angiogenic Factors and Interleukin 15 in Uteroplacental Unit of Preeclamptic Rats on Pregnancy Day 21 After Anti-Asialo GM1 Application
We further investigated the uteroplacental units of preeclamptic rats on pregnancy day 21. In the placenta, the fetal part of the uteroplacental unit, anti-asialo GM1 application decreased soluble, fms-like tyrosine kinase 1 (sFLT-1; Figure S4A ) and placental growth factor (PlGF; Figure S4B ) protein concentration, leading to an unchanged sFLT-1/PlGF ratio in preeclamptic rats ( Figure S4C ). Gene expression of sFLT-1 and PlGF in placenta was not different between the 2 preeclamptic groups (data not shown). In mesometrial triangle of preeclamptic rats, the maternal part of the uteroplacental unit, there was neither Figure 1 . Reduction of natural killer cells on pregnancy day 15 in preeclamptic (PE) rats. A, Anti-asialo GM1 reduced natural killer cells (NK cells) in the maternal spleen of PE rats on pregnancy day 15 by 80% (n=3 per group). Two-color, flow cytometry contour plots displaying CD161 fluroesceinisothiocyanate (FITC) vs CD3 allophycocyanin (APC), or isotype control. B, Histological section images from the mesometrial triangle on day 15 of pregnancy of a control, rabbit serum-treated and an anti-asialo GM1-treated PE rat, respectively, ×20 magnification. Immunohistochemical staining with anti-natural killer cell activation structures (ANK61) to detect uterine natural killer cells (uNK cells), which appear in black after nitro-blue tetrazolium chloride and 5-bromo-4-chloro-3′-indolylphosphate p-toluidine salt staining and counterstaining with periodic acid-Schiff and hematoxylin. Anti-asialo GM1 reduced uNK cells in the mesometrial triangle of PE rats on pregnancy day 15. C, Quantification of the ANK61-positive staining of mesometrial triangles of PE rats on pregnancy day 15. Positive cells were evaluated semiquantitatively by counting them in 3 complete microscopic fields per mesometrial triangle (n=3 mesometrial triangles from anti-asialo GM1-treated PE rats and n=3 mesometrial triangles from control rabbit serum-treated PE rats, all mesometrial triangles from different mother rats). Antiasialo GM1 reduced the mean number of ANK-positive cells in the mesometrial triangle by 60% (60±8 cells per microscopic field in ×40 magnification vs 150±15 cells in the PE, control, rabbit serum-treated group; P<0.0001, unpaired t test, (Continued ) Figure 1 Continued. shown mean with SEM); n=9 microscopic fields per group. D, In the mesometrial triangle of PE rats on pregnancy day 15, rat natural cytotoxicity receptor 1 (rNCR1, NKp46) mRNA, mainly specifically expressed on NK cells, was reduced by 89% after anti-asialo GM1 application, measured by quantitative, real-time, reverse transcription polymerase chain reaction (n=2 anti-asialo GM1-treated, PE rats and n=4 control, rabbit serum-treated PE rats). The amount of uNK cells in the mesometrial triangle of control, rabbit serum-treated PE rats decreased from day 15 to day 21 by 95% (n=5; P=0.01). The decrease of uNK cells in mesometrial triangle from control, rabbit serum-treated PE rats on pregnancy day 15 to anti-asialo GM1-treated PE rats on pregnancy day 21 Figure S4A ) and PlGF ( Figure S4B ), nor in the ratio of both ( Figure S4C ). Gene expression displayed similar results (data not shown). The sFLT-1/PLGF ratio in maternal preeclamptic plasma at the end of pregnancy was also unchanged ( Figure S4D ). Antiasialo GM1 decreased gene expression of interleukin 15 in the preeclamptic placenta by 14% ( Figure S4E ) and increased it in the mesometrial triangle by 47%.
Influence of Anti-Asialo GM1 Application on Fetal Outcome and Maternal Phenotype in Preeclamptic Rats on Pregnancy Day 21
We then analyzed the influence of anti-asialo GM1 treatment on fetuses of preeclamptic rats, concentrating on intrauterine growth retardation on pregnancy day 21. Anti-asialo GM1 application increased fetal brain/liver weight ratio in preeclamptic rats ( Figure 4A ). Fetal liver weight ( Figure S5A ) was decreased, whereas fetal brain weight ( Figure S5B ) and total fetal weight ( Figure 4B ) in preeclamptic rats remained unchanged. There was neither a difference in the number of fetuses ( Figure S5C ), nor in the number of resorptions per mother rat ( Figure S5D ) between the 2 preeclamptic groups. In preeclamptic mother rats, NK cell reduction did not influence the preeclampsia-defining signs, hypertension ( Figure 4C ) and albuminuria ( Figure S5E ). Systolic and diastolic blood pressure measured by telemetry showed no difference between both preeclamptic groups (data not shown). Additionally, serum creatinine ( Figure S5F ), serum cystatin C ( Figure S5G ), and maternal body weight ( Figure S5H ) were not changed in preeclamptic rats after anti-asialo GM1 application. The uteroplacental units ( Figure 4D ) were heavier, and the uteroplacental unit/fetal weight ratio ( Figure 4E ) was increased in preeclamptic rats after anti-asialo GM1 application.
Influence of Anti-asialo GM1 Application in WildType Rats on Pregnancy Day 21
We finally investigated the influence of anti-asialo GM1 application on healthy, wild-type, SD rats on pregnancy day 21. Anti-asialo GM1 or rabbit serum, respectively, was applied according to the same protocol used in our preeclamptic rats. We found uterine maternal vasculopathy in 66.7% (4/6) of anti-asialo GM1-treated, SD mother rats ( Figure 5A ). None of the rabbit serum-treated, control SD mothers displayed uterine vasculopathy. One anti-asialo GM1-treated, SD mother rat carried 11 implantation sites with 10 resorptions and 1 highly growth-restricted fetus (1.6 g). In the center of this specimen's mesometrial triangle ( Figure 5B), there was a large area completely lacking nuclear staining. Within this area, we discovered several vessel cross sections displaying vasculopathy and increased terminal deoxynucleotidyl transferase dUTP nick end labeling positivity. In SD rats, anti-asialo GM1 decreased fetal weight significantly (3.7 versus 3.9 g in the control rabbit Figure 2 . Influence of anti-asialo GM1 on maternal uterine vessels in preeclamptic (PE) rats on pregnancy day 21. Photomicrographs of degenerative maternal vasculopathy in the mesometrial triangle of PE rats. In every anti-asialo GM1-treated, PE rat (n=7), we found at least one degenerative vessel cross section with massive fibrosis. In control, rabbit serum-treated PE rats (n=5), just one mother rat displayed vasculopathy. Shown are representative parallel stainings of an anti-asialo GM1-treated, PE rat and a control, rabbit serum-treated PE rat. A, Masson-Goldner trichrome staining, which typically stains collagen green. Around the vessels in the anti-asialo GM1-treated, PE rat, there is a huge perivascular collagen accumulation/fibrosis, which is not present in the control, rabbit serum-treated PE mesometrial triangle. The lumen of the spiral artery in the anti-asialo GM1-treated, PE rat seems almost totally filled with cells and exudate with just a minority being erythrocytes (red in Masson-Goldner trichrome staining). B, Periodic acid-Schiff (PAS) staining and counterstaining with hematoxylin. In the anti-asialo GM1-treated, PE rat, there are a lot of rounded cells, which have lost their connectivity. These cells show no nuclear staining with hematoxylin, indicating an advanced cell damage. C, Diaminobenzidine staining of α-actin and counterstaining with PAS and hematoxylin, after which smooth muscle cells usually appear in brown. In the wall of degenerative vessels (in the anti-asialo GM1-treated, PE rat), there was no α-actin of smooth muscle cells detectable anymore. D, Cytokeratin staining of trophoblast cells, which appear in black after nitro-blue tetrazolium chloride (NBT) and 5-bromo-4-chloro-3′-indolylphosphate p-toluidine salt (BCIP) staining and counterstaining with PAS and hematoxylin. The degenerative vessel cross sections in the anti-asialo GM1-treated PE rat are hardly infiltrated by endovascular trophoblast cells, whereas there are a lot of interstitial trophoblast cells present. E, CD31 staining of endothelial cells (NBT and BCIP staining and (Continued ) Figure 2 Continued. counterstaining with PAS and hematoxylin), which is still present in the degenerative spiral artery cross sections in the PE rat after anti-asialo GM1 therapy, but already weaker in comparison to a nondegenerative spiral artery cross section. All pictures in ×20 magnification. Figure 5C ). Fetal brain/liver weight ratio ( Figure 5D ; Figure S6A and S6B), weight of uteroplacental unit ( Figure 5E ), and the uteroplacental unit/fetal weight ratio ( Figure 5F ) were unchanged between both SD groups. Moreover, maternal blood pressure, albuminuria, and number of fetuses and resorptions were not changed after anti-asialo GM1 treatment in SD rats in comparison to rabbit serumtreated SD rats (data not shown).
Discussion
We successfully reduced NK cell numbers in our preeclamptic rats by administering anti-asialo GM1 antiserum. This effect was associated with a pathological phenotype at the fetal-maternal interface. Maternal uterine vasculopathy with presumably dead cells in the vessel wall and in the perivascular zone occurred in every preeclamptic and in the majority of wild-type SD rats after anti-asialo GM1 application. The vasculopathy was associated with a deterioration of fetal outcome, which was more pronounced in SD rats where fetal weight was reduced. Fetuses of preeclamptic rats displayed signs of growth restriction (increased fetal brain/liver weight ratio as a marker for fetal centralization) after anti-asialo therapy. Reduction of NK cells by anti-asialo GM1 administration diminished the area and the density of interstitial trophoblast cell invasion in preeclamptic rats. There was no change in blood pressure and albuminuria neither in preeclamptic nor in SD rats after anti-asialo GM1 treatment.
A vasculopathy associated with NK cell reduction in hypertensive pregnancy has heretofore never been shown. These data agree with seminal earlier work showing that absent NK cells during normotensive murine pregnancy is associated with uterine vasculopathy suggestive of arteriosclerosis and fetal loss. 23 Moreover, others have demonstrated involvement of uNK cells in decidual angiogenesis that supports fetal growth during early and mid pregnancy. 24 We observed degenerated maternal vessels with massive dead tissue and fibrosis in the mesometrial triangle of NK-reduced animals. We are aware that identifying vascular smooth muscle cell degeneration is difficult and that absent nuclear staining in perivascular cells as signs of an expanding degeneration of the surrounding tissue is imprecise. We interpret our result a nonspecific degenerative process, involving also the perivascular area. Isolated round cells with a loss of connectivity were occasionally observed in other mesometrial triangles, either anti-asialo GM1-treated or in control rabbit serum-treated rats; however, on a much smaller scale.
Our findings could also suggest that NK cells are involved in maintenance and protection of the maternal uterine vascular system, perhaps even with long-term implications. The vasculopathy was associated with fetal growth restriction in wild-type SD rats, and subtle signs of fetal growth restriction effects were observed in preeclamptic rats, even though these fetuses were already extremely growth restricted (>20% growth restriction in comparison to healthy wild-type SD fetuses). We hypothesize that the vasculopathy arose during the last third of pregnancy because we did not observe vasculopathy in mesometrial triangles of preeclamptic rats on pregnancy day 15 (data not shown). We regard the vasculopathy as representing final exhaustion at the end of pregnancy when the stress exerted on the maternal cardiovascular system increases significantly. In addition, the degenerated vessels with absence of intraluminal cells could explain why we could not reproduce the results reported by Chakraborty et al. 16 They reported increased endovascular trophoblast cell invasion on pregnancy day 14 in wild-type rats after antiasialo GM1 administration. In our study of preeclamptic rats on pregnancy day 21, endovascular trophoblast cell invasion was not different from controls. Besides vasculopathy, this conflicting result could also be because of the different time points of analysis and the fact that Chakraborty et al used healthy wild-type rats, whereas we tested NK cell reduction in a transgenic preeclamptic model. Chakraborty et al did Figure 3 . Maternal uterine vasculopathy in preeclamptic (PE) rats on pregnancy day 21 after anti-asialo GM1 application. A, Quantification of the incidence of maternal vasculopathy in the mesometrial triangle (uterus). In every anti-asialo GM1-treated, PE mother rat (n=7; 7/7, 100%), we found at least one degenerative vessel. In control, rabbit serum-treated PE rats (n=5), just one mother rat displayed vasculopathy The second important finding of our study was the decreased interstitial trophoblast cell invasion in preeclamptic rats with reduced number of NK cells. In humans and rats, trophoblast cells invade the uterine interstitium 25, 26 and the lumina of spiral arteries. 27, 28 In rats, interstitial trophoblast cell invasion occurs after endovascular invasion. 25 This finding again supports our hypothesis that the observed vasculopathy occurred at the end of pregnancy, hampering physiological interstitial trophoblast cell invasion and a putative (according to Chakraborty et al 16 ) increased endovascular trophoblast cell invasion. The increased weight of the uteroplacental unit in anti-asialo GM1-treated preeclamptic rats and especially their increased uteroplacental unit/fetal weight ratio could reflect placental insufficiency as a consequence of decreased trophoblast cell invasion. Traditionally, an increased placental/fetal weight ratio has been used as a marker for an inefficient placenta. 29 An alternative way to demonstrate placental insufficiency would be to study umbilical Doppler images, which should be considered in further experiments. The decreased interstitial trophoblast cell invasion is in accordance with earlier work showing that in humans decidual NK cells, but not peripheral bloodderived NK cells, support trophoblast cell invasion and induce angiogenesis in the decidua. 30 These processes are 2 important events in early pregnancy. Recently, Kieckbusch et al showed that a major histocompatibility complex-mediated inhibition of uNK cells leads to slightly diminished fetal growth and altered spiral artery remodeling in mice. 31 Reduction of NK cells did not change spiral artery remodeling in our preeclamptic rats, but we could show a decrease in fetal weight in our wild-type SD rats after NK cell reduction. The mouse model is problematic because murine intrauterine trophoblast cell invasion is shallow 32 compared with humans and rats. Figure 4 Continued. anti-asialo GM1 PE group and n=55 in the control, rabbit serum-treated, PE group. B, Anti-asialo GM1 application did not change fetal weight in PE mother rats (2.8 vs 2.9 g in the control, rabbit serum-treated group; P=0.3, Mann-Whitney test, shown median with interquartile range); n=73 in the anti-asialo GM1-treated, PE group and n=56 in the control, rabbit serum-treated PE group. C, Anti-asialo GM1 treatment of PE rats did not change maternal blood pressure during pregnancy. Blood pressure was measured on 16 days throughout pregnancy, and there was no difference at any time in mean arterial blood pressure between the anti-asialo GM1-treated, PE and the control, rabbit serum-treated PE group (eg, 155±3 vs 158±4 mm Hg in the control, rabbit serum-treated PE group on pregnancy day 17; P>0.99, repeated-measures 2-way ANOVA, Bonferroni multiple comparisons test, shown mean with SEM); n=7 PE mother rats in the anti-asialo GM1-treated group and n=5 PE mother rats in the control, rabbit serum-treated group. D, Anti-asialo GM1 increased mean weight of the uteroplacental unit in PE rats (546±9 vs 490±10 mg in the control, rabbit serum-treated PE group; P<0.0001, unpaired t test, shown mean with SEM); n=73 in the PE anti-asialo GM1-treated group and n=56 in the PE, control, rabbit serum-treated group. E, The uteroplacental unit/fetal weight ratio was increased after antiasialo GM1 therapy in PE rats (0.20 vs 0.18 in the control, rabbit serum-treated PE group; P<0.0001, Mann-Whitney test, shown median with interquartile range); n=73 in the PE anti-asialo GM1 group and n=56 in the PE control rabbit serum group. A, B, D, and E, Fetuses and uteroplacental units out of n=7 anti-asialo GM1-treated PE mother rats or n=5 normal, rabbit serum-treated PE mother rats, respectively. *P<0.01, ****P<0.0001. Natural killer cells are part of the innate immune system and characterized by interferon γ production influencing immune cells of the adaptive immune system. Interestingly, there is increasing evidence that NK cells are related to the growing family of innate lymphoid cells (ILCs). 33, 34 Several ILCs express markers such as NKp46 that were formerly considered to be exclusively expressed on NK cells. 34 ILCs are non-T and non-B cells mirroring functions of T cells but with prompt reaction to antigens or injured tissues. 35 Their presence is locally enriched in barrier surfaces. 36 On the basis of the signature cytokines they produce, 34 there are 3 classes of ILCs (ILC1, ILC2, and ILC3) at the moment. Group 1 consists of interferon-γ-producing cells and thus NK cells are considered to belong to the ILC1 group. However, NK cells can still be distinguished because they display cytotoxicity and because their maturation depends on the transcription factor eomesodermin. 37, 38 Furthermore, the transcriptional program of NK cells differs, at least in parts, from that of ILC1s. 33 Thus, they are still commonly referred to as NK cells. 35 Taken together, the quickly emerging, complex types and subtypes of ILCs in addition to their potential for interconversion between ILC groups 39 make a clear identification of ILC types and their distinction from other immune cells almost impossible with current techniques. Thus far, there has not been any description of ILCs in the rat, but it is likely that they exist there as well. Although we cannot claim that we also reduced ILC1s and other ILCs in our study, we can conclude on the basis of our results and current knowledge that we have reduced what is considered to be NK cells in the spleen and uterus at the moment.
Traditionally, NK cells have been considered as a homogenous lymphocyte population circulating in blood, spleen, and other organs (circulating NK cells). However, there is clear evidence that subtypes of NK cells reside in tissues (tissue-resident NK cells) such as liver, thymus, uterus, 40 and the salivary gland 41 exhibiting different functions and capabilities. Strikingly, tissue-resident NK cells do not seem to require the NK cell specification transcription factor Nfil3 (nuclear factor interleukin-3-regulated Figure 5 . Influence of anti-asialo GM1 on fetal outcome and maternal uterine vessels in wild-type, Sprague-Dawley (SD) rats on pregnancy day 21. A, Quantification of maternal vasculopathy in the mesometrial triangle of SD rats on pregnancy day 21: application of anti-asialo GM1 (n=6) induced in 4 of 6 SD mother rats (4/6, 66.7%) a vasculopathy (according pictures from Figure  2 ). There was no vasculopathy in any rabbit serum-treated, SD mother rat (n=5, 0/5, 0%). B, Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay (red) to detect apoptotic cells with 4′,6-diamidino-2-phenylindole staining (blue) for visualization of cell nuclei. Uteroplacental unit of a highly growth-restricted fetus (1.6 g) in a SD mother rat after anti-asialo GM1 application. There is a large area of absent nuclear staining in the middle of the picture. Within this area, there is TUNEL positivity. ×10 magnification. C, Anti-asialo (Continued ) Figure 5 Continued. GM1 decreased fetal weight in SD mother rats (3.7 vs 3.9 g in the SD control rabbit serum group; P=0.02, Mann-Whitney test, shown median with interquartile range); n=50 fetuses out of n=6 anti-asialo GM1-treated, SD mother rats and n=46 fetuses out of n=6 normal, rabbit serum-treated SD mother rats. D, Anti-asialo GM1 application did not change fetal brain/liver weight ratio in fetuses of SD mother rats (0.5 vs 0.5 in the SD control rabbit serum group; P=0.4, Mann-Whitney test, shown median with interquartile range); n=50 fetuses out of n=6 anti-asialo GM1-treated, SD mother rats and n=46 fetuses out of n=6 normal, rabbit serum-treated SD mother rats. E, Anti-asialo GM1 treatment of SD rats did not change the weight of the uteroplacental unit (681±12 vs 703±12 mg in the SD control rabbit serum group; P=0.2, unpaired t test, shown mean with SEM); n=49 fetuses out of n=6 anti-asialo GM1-treated SD mother rats and n=43 fetuses out of n=5 normal, rabbit serum-treated SD mother rats. F, There was no difference in the uteroplacental unit/fetal weight ratio after anti-asialo GM1 therapy in SD rats (0.19±0.00 vs 0.18±0.01 in the SD control rabbit serum group; P=0.1, unpaired t test with Welch correction, shown mean with SEM); n=49 fetuses out of n=6 anti-asialo GM1-treated, SD mother rats and n=43 fetuses out of n=5 normal, rabbit serum-treated, SD mother rats. *P<0.01.
by guest on October 15, 2017 http://hyper.ahajournals.org/ Downloaded from protein), 41 leading to the assumption that tissue-resident NK cells are distinct from circulating NK cells and could represent a different cell lineage. 40 The independence of Nfil3 has been shown for uNK cell differentiation in mice as well. 42 Tissue-resident NK cells in the liver develop independent of eomesodermin, 43 whereas tissue-resident NK cells in the uterus highly express eomesodermin, 44 suggesting more similarities of uNK cells to circulating NK cells. However, the precise origin of uNK cells remains unclear. Nevertheless, tissue-resident NK cells seem to be distinguishable from each other and in parts from ILCs. 40 Recently, a population of nonkiller uterine ILC3s has been found in human endometrium and decidua. 45 Rat uNK cells have not well been characterized recently 46 and, to our knowledge, rat uterine ILCs have never been described.
We used a published, successful protocol to reduce NK cells in rats 16 by administering anti-asialo GM1 antiserum. This antiserum reduces NK cells in almost every organ in the body, including spleen 16, 47 rather than just uNK cells. Moreover, anti-asialo GM1 also reacts with nonparenchymal liver cells, 48 T cells in mice 49 and rats, 50 as well as murine basophils 51 and monocytes 52 and rat granulocytes and macrophages. 50 The effect on various ILC subsets is poorly described. Thus, we cannot conclude that the effects we observed were solely the result of NK or even uNK cell reduction. Because the pregnant uterus contains relatively few immune cells with uNK cells representing the major population, we consider a relevant local effect mediated by other cells unlikely. Considering the heterogeneity of uNK cells in mouse and human, the effects of anti-asialo GM1 treatment reported herein may rely on the reduction of one of the subsets. One study found that antiasialo GM1 does not deplete tissue-resident NK cells in the kidney. 53 But within that same article, the authors have shown that uterine tissue-resident NK cells seem to be an exception because they were uniformly expressing high levels of asialo GM1 that was similar to circulating NK cells in some strains. 53 Currently, the only way of temporarily depleting or reducing NK cells in the rat is administering antibodies or the antiserum anti-asialo GM1. Other groups have also successfully relied on this approach. 16, 46, 54 We detected an increase in interleukin-15 gene expression in the mesometrial triangles of anti-asialo GM1-treated, preeclamptic rats at the end of pregnancy. In humans, interleukin-15 is expressed by endometrial stromal cells 55 and involved in recruitment of uNK cells to the endometrium.
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One could interpret the increase in interleukin-15 in the mesometrial triangle after NK cell reduction as a homeostatic, compensatory mechanism to replenish the uNK cell population, confirming the successful reduction of NK cells in the uterus.
The importance of uNK cells in the maintenance of pregnancy, particularly in late gestation, is still imperfectly understood. 57 Earlier animal investigations did not address disease processes such as hypertension in pregnancy or preeclampsia. We found vascular pathology in preeclamptic rats when NK cells are reduced, but we did not observe any effect on blood pressure and albuminuria. The data from our animal model do not support a major role for NK cells in this experimental preeclampsia but definitely indicate an effect on uterine maternal vasculopathy and fetal growth.
Perspectives
An effect of natural killer cells on the preeclamptic phenotype could not be supported by our results. However, their reduction exerts a degenerative vascular effect on the maternal side of the uteroplacental unit that is associated with fetal growth restriction in wild-type rats. These complex results nonetheless direct a therapeutic focus on new targets. Viewing preeclampsia as a NK cell disease in terms of modulation would be a shift from current thinking. Because no therapeutic options have developed for patients, this method of thought could direct future ideas.
What Is New?
• We report the first interventional study of reducing natural killer cells in an established rat model for preeclampsia.
• Substantial reduction of natural killer cells is not altering the preeclamptic phenotype.
• We are the first to describe that reduction of natural killer cells induces maternal uterine vasculopathy in hypertensive rat pregnancy.
What Is Relevant?
• In preeclamptic rats, reduction of natural killer cells alters the uteroplacental unit with a decrease in interstitial trophoblast cell invasion and an induction of maternal vasculopathy with degenerative vessels exhibiting excessive fibrosis, but it did not modify maternal hypertension and albuminuria. In wild-type rats, reduction of natural killer cells also induces maternal uterine vasculopathy, which is associated with fetal growth restriction. The work directs attention to a different and novel aspect of immunology.
Summary
This study demonstrates a role for natural killer cells in trophoblast cell invasion and in maintenance of vascular integrity in the uterus needed for fetal growth. 
Novelty and Significance
Materials and Methods
Animals and procedures
Local German authorities approved the studies that were conducted in accordance with the National Institutes of Health (NIH) guide for the care and use of laboratory animal standards. Our model involves two Sprague-Dawley rat lines: female rats expressing the human angiotensinogen (hAOGEN) and male rats expressing the human renin (hREN) gene. After mating, the dam develops severe hypertension 1 and some target organ damage in the second half of pregnancy.
2 At the end of pregnancy, the fetuses exhibit low birth weight and increased brain/liver weight ratio compared to normal non-transgenic Sprague-Dawley offspring confirming intrauterine growth restriction. 3 The placentas in preeclamptic (PE) dams are lighter than those in control rats. 4 Together with the group of Robert Pijnenborg, we had investigated the uteroplacental unit in this model and had shown a pathological endovascular trophoblast cell invasion with an altered uteroplacental vascular remodeling. [5] [6] [7] Ganglio-N-tetraosylceramide (asialo GM1) is a glycolipid expressed on natural killer cells (NK cells) in mice, 8 rats, 9 and humans. 10 The antiserum anti-asialo GM1 successfully depletes NK cells in mice 8 and rats. 11 It also depletes uterine NK cells (uNK cells). 11 We administered 0.5 ml rabbit anti-asialo GM1 antiserum (Wako Pure Chemical Industries) to pregnant dams intraperitoneally on day 5 and day 10 of pregnancy according to a protocol published by other investigators earlier.
11 Pregnancy day 1 was defined by the presence of a vaginal copulation plug. Control PE rats received 0.5 ml rabbit serum (Jackson ImmunoResearch Laboratories). Rats from each group were anesthetized and euthanized for analysis either on day 15 or day 21 of pregnancy. Preeclamptic pregnant rats observed until pregnancy day 21 received continuous blood pressure monitoring by radiotelemetry (Data Science International). In healthy wild type Sprague-Dawley rats (SD), blood pressure was obtained by tail cuff measurement on pregnancy days 5, 10, 15/16, and 20/21. For quantification of 24 hours albumin excretion, rats were placed in metabolic cages and urine was collected (on pregnancy day 18/19 in PE rats, and on pregnancy day 17/18 in SD rats). Urinary albumin excretion was analyzed by ELISA (CellTrend). Serum cystatin C was determined by ELISA (BioVendor) according to manufacturer´s protocol. Serum creatinine was assessed by an automated clinical method (HELIOS Klinikum Berlin-Buch). In our study, we examined two different rat strains, transgenic PE Sprague-Dawley rats and healthy wild type SD rats. Maternal blood pressure, albuminuria, fetal and uteroplacental weights and ratios, and analysis of uterine vasculopathy has been evaluated in PE mother rats (n=7 anti-asialo GM1-treated rats and n=5 normal rabbit serum-treated rats) and SD mother rats (n=6 or 7 anti-asialo GM1-treated rats and n=5 or 6 normal rabbit serum-treated rats) on pregnancy day 21. Proof of NK cell reduction has been performed in PE rats on pregnancy day 15 (flow cytometry spleen: n=3 anti-asialo GM1-treated rats and n=3 normal rabbit serum-treated rats; histology uterus: n=3 anti-asialo GM1-treated rats and n=3 normal rabbit serum-treated rats; gene expression uterus: n=2 anti-asialo GM1-treated rats and n=4 normal rabbit serum-treated rats). Histological evaluation of trophoblast cell invasion and spiral artery remodeling has been performed in PE rats on pregnancy day 21 (n=8 uteroplacental units out of 7 anti-asialo GM1-treated rats and n=5 uteroplacental units out of 5 normal rabbit serum-treated rats). Maternal angiogenic profil in plasma has been evaluated in PE rats on pregnancy day 21 (n=7 anti-asialo GM1-treated rats and n=5 normal rabbit serum-treated rats). Gene expression of interleukin 15 in the uteroplacental unit has been analyzed in PE rats on pregnancy day 21 (n=5 out of 7 anti-asialo GM1-treated rats and n=5 out of 5 normal rabbit serum-treated rats). Angiogenic profil of the uteroplacental unit has been analyzed in PE rats on pregnancy day 21. Maternal serum creatinine, cystatine C, and body weight has been evaluated in PE rats on pregnancy day 21 (n=7 anti-asialo GM1-treated rats and n=4 or 5 normal rabbit serum-treated)
RNA isolation, reverse transcription polymerase chain reaction and protein isolation
We isolated total mRNA from mesometrial triangle and placentas (together called uteroplacental unit) using QIAzol Lysis Reagent, RNeasy Mini Kit, and RNase-Free DNase Set (all Qiagen) according to the manufacturer´s protocol. Then, RNA was transcribed into cDNA by the High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems) with a DNA Thermal Cycler (Perkin Elmer) and analyzed in triplicates by real time quantitative polymerase chain reaction on 7500 Fast Real-Time PCR System (Applied Biosystem). Results were normalized to 18s. We designed our primers and probes (BioTeZ Berlin Buch GmbH) with Primer Express 3.0 (Applied Biosystems). Sequences are listed in the Supplementary Table S1 . Proteins were isolated by homogenization in radioimmunoprecipitation assay buffer (RIPA buffer) supplemented with proteinase inhibitors. The placental like growth factor (PlGF) protein concentration was measured with the mouse PlGF-2 Quantikine ELISA Kit (R&D Systems), the soluble fms-like tyrosine kinase 1 (sFLT-1) protein concentration with the rat sFLT-1 ELISA Kit (MyBioSource).
Flow cytometry
Preeclamptic rats having received anti-asialo GM1 (n=3) or normal rabbit serum (n=3), respectively, on pregnancy days 5 and 10 were euthanized on pregnancy day 15. Spleen was removed and a single cell suspension established by mechanical disintegration. After incubation in erythrolysis buffer (NH4Cl, NaHCO3, EDTA) cells were labeled with fluoresceinisothiocyanate (FITC)-conjugated mouse anti-rat CD161 (mouse IgG1 κ, clone 10/78, Biolegend, CA, USA) and allophycocyanin (APC)-conjugated mouse anti-rat CD3 (clone 1F4, BD PharmingenTM). For isotype control, cells were stained with FITCconjugated mouse IgG1 κ (clone MOPC-21, BioLegend). Flow cytometry was performed with a BD FACSCantoTM II (BD Biosciences). Data were analyzed with Flow Jo (Tree Star Inc.). Quantification of NK cells was performed on the lymphocyte population.
Tissue preparations
We worked according to a published protocol with minor modifications. 6 After the rats were sacrificed, placentas and associated mesometrial triangles were removed and fixed for 48 hours at room temperature in a fixative according to Backstead, 12 which is a zinc-based formaldehyde-free fixative consisting of Tris(hydroxymethyl)-aminomethan-buffered calcium acetate (0.05%), zinc acetate (0.5%), and zinc chloride (0.5%). After fixation, the uteroplacental units were transferred to 70% ethanol and embedded in paraffin according to standard procedures. Then several series of ten parallel sections were cut from each uteroplacental unit. The distance between two series was at least 100 μm. Every section was 3 -5 μm thick. For further analysis, we selected one set displaying the most central parts of the uteroplacental unit. Within this set, a Masson-Goldner trichrome staining was performed. Additionally, parallel sections were stained with Periodic Acid Schiff (PAS; for general morphological evaluation and detection of fibrinoid), α-actin (marker for vascular smooth muscle cells, VSMC), cytokeratin (marker for trophoblast cells), CD31 (marker for endothelial cells), and Anti-Natural Killer Cell Activation Structures (ANK61, marker for NK cells; abcam).
Immunohistochemistry and quantitative analysis of trophoblast cells
We applied a protocol published earlier. 6 We used non-conjugated goat anti-mouse immunglobulins (Acris Antibodies) at a final dilution 1:50 and mounted the stained sections in Depex mounting medium (VWR international GmbH) or Aqua-Poly/Mount (Polysciences, Inc.), respectively. We worked with the program AxioVision 4.1 linked to our Zeiss microscope Axio Imager M2 fitted with a camera AxioCam HRc (all Zeiss). Overview images of the whole uteroplacental unit were developed by using the module 'panorama' (Zeiss). Areas of mesometrial triangle and interstitial trophoblast cell invasion into mesometrial triangle were measured on the overview picture of the most central part of the uteroplacental unit with the module 'interactive measurements' (Zeiss). The mesometrial triangle was defined as the uterine tissue between the two uterine muscle layers. Numbers of trophoblast cells invading into the mesometrial triangle were semiquantitatively evaluated by counting trophoblast cells in microscopic fields at 40 x magnification. We only evaluated microscopic fields containing exclusively mesometrial triangle tissue without large blood vessels and according to availability, four to six randomly assigned fields were evaluated per uteroplacental unit without differentation between interstitial and endovascular trophoblast cells. Counts of 42 microscopic fields totalized from all anti-asialo GM1-treated uteroplacental units were compared to counts from 29 microscopic fields totalized from all control rabbit serum-treated uteroplacental units. Endovascular trophoblast cell invasion was evaluated by examining every endovascularly invaded spiral artery cross section within the mesometrial triangle. The extension of endovascular trophoblast cell invasion was evaluated by scoring the percentage of vessel lumen circumference infiltrated by trophoblast cells as indicated by cytokerating positivity (1 point: 0-25%; 2 points: 26-50%; 3 point: 51-75%; 4 points: 76-100%). In case of very low and/or very thin antigen positivity (for cytokeratin), we diminished the score by one. Scores of spiral artery cross sections from all anti-asialo GM1-treated uteroplacental units (n=271 from 8 uteroplacental units) were compared to scores from all control rabbit serumtreated uteroplacental units (n=188 from 5 uteroplacental units). The same score and analysis were applied to investigate the amount of smooth muscle cell tissue within the vessel wall. We interpreted a lower score (representing loss of smooth muscle cells) as vascular remodeling of the spiral artery.
